Memorial Sloan Kettering Cancer Center’s Post

From our special issue on ocular oncology, this article reviews current and emerging treatment options for retinoblastoma, with a focus on recent studies investigating the application of different types of nanoparticles for the diagnosis and treatment of this condition. https://lnkd.in/e827G3NC #Ophthalmology #ClinicalResearch #OcularOncology #Retinoblastoma

Join us today at 3:20pm PT at the annual Society of Gynecological Oncology #SGOMtg as we present results from our #ovariancancer phase 3 trial in Chinese patients, in a late-breaking session. Learn more here: https://bit.ly/3PbPlBF #conference #oncology

New data from our study in people with KRAS G12C-mutant advanced solid tumors, including in #NonSmallCellLungCancer (NSCLC), will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.    Learn more about the results: https://e.lilly/3V892g9 #ASCO24  

This Annals of Surgical Oncology #FeaturedArticle helps bring definition to the biology of estrogen receptor-low-positive #BreastCancer. 📃: https://lnkd.in/gbmy4qMf

Check out the first meeting of the AI Community of Practice at American Society of Clinical Oncology (ASCO) - Ravi B. Parikh #AI #ClinicalOncology #ASCO24 #Cancer #OncoDaily #Oncology

🌟🔬 Discover the capabilities of the digital #RANOassessment tool with Dr. Gerry Thompson from the University of Edinburgh in our on-demand webinar. Learn about its features and applications in oncology. 🔗 Watch now: https://hubs.la/Q02X47T30 #Neuroncology #DigitalHealth #MedicalInnovation #HealthcareTech #GBM #CancerResearch

New 10-year data from a randomized trial sheds light on the survival outcomes of cytoreduction and HIPEC with mitomycin C vs. oxaliplatin for appendiceal neoplasm with peritoneal dissemination. These findings provide critical insights for tailoring HIPEC treatments. Read the full study in Annals of Surgical Oncology: https://lnkd.in/gbmy4qMf #FeaturedArticle

From our special issue on ocular oncology, this brief review highlights issues with the current classification systems for intraocular retinoblastoma (ICRB and IIRC) and presents a theoretical framework for merging 2 existing classifications and subdividing the expanded group E, thereby preserving the ability to reanalyze existing published data. https://lnkd.in/ezYCHwy7 #Ophthalmology #VisionScience #OcularOncology #Retinoblastoma

This Annals of Surgical Oncology #FeaturedArticle features a study that evaluated the prognostic value of biological and conditional factors for resectable pancreatic ductal adenocarcinoma (PDAC). https://lnkd.in/gbmy4qMf

An overview of the exciting genitourinary oncology data to come at ASCO24 - Karine Tawagi University of Illinois Chicago American Society of Clinical Oncology (ASCO) #ASCO24 #Cancer #GenitourinaryOncology #OncoDaily #Oncology